To view this email as a web page, click here.

DRUG APPROVALS
 
Once-daily diabetes drug approved
Type 2 diabetes patients have a new therapy option with a new once-daily combination drug from AstraZeneca.
Read more
 
Drug approved for nighttime urination, plus 2 more FDA approvals
FDA recently approved a new drug for nighttime urination, plus one for dust mite allergies and a particular type of diarrhea affecting some cancer patients.
Read more
 
CONTINUING PHARMACY EDUCATION
 
Human papillomavirus (HPV) vaccine: updated recommendations and strategies to improve
This month's CE activity, "Human papillomavirus (HPV) vaccine: updated recommendations and strategies to improve," is open for pharmacists and pharmacy technicians.

The goal of this activity is to provide pharmacists with updated recommendations and strategies on the human papillomavirus (HPV) vaccine.

Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics.
More
 
EDITOR'S PICK
 
HIV dual therapy shows promise
A dual-drug regimen to treat HIV could soon be a reality, according to results presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle.
Read more
 
RELATED ARTICLES
 
New diabetes drug enters competitive market
Why new bladder cancer drug is novel
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.